Parkinson's disease

 "Before starting antiparkinsonian treatment, the patient's individual circumstances, including symptoms, comorbidities and preferences, should be discussed together with the potential benefits and harms from the different drugs available. 

Patients and their carers should be informed about the risk of adverse reactions from antiparkinsonian drugs, including psychotic symptoms, excessive sleepiness and sudden onset of sleep with dopamine-receptor agonists, and impulse control disorders with all dopaminergic therapy (especially dopamine-receptor agonists). For further information see Impulse control disorders."

"To avoid the potential for acute akinesia or neuroleptic malignant syndrome, antiparkinsonian drug concentrations should not be allowed to fall suddenly due to poor absorption or abrupt withdrawal."

https://www.medicinescomplete.com/#/content/bnf/_661075101

++++++++++++++++++++++++++++++++++++++++++++++++++++

Disclaimer: the main purpose of this blog is to assemble my notes for my Continuing Professional Development (CPD). The topic discussed here should not be referred to as the only source of information use it in combination. It should be used with other established reference sources. If you are using it significantly after the date of initial publication, then you should refer to current published evidence. 

.If the content of this article concerns you, please contact your doctor or pharmacist

 مطالب مندرج در این وبلاگ صرفا برای اطلاع رسانی و افزایش آگاهی در رابطه با سلامت و بهداشت می باشد و الزاما مرجع کاملی در رابطه با موضوع مورد بحث نمی باشد. برای اطلاعات بیشتر جهت درمان، قطع یا تغییر نوع درمان با پزشک معالج یا داروساز خود مشورت نمایید

 ++++++++++++++++++++++++++++++++++++++++++++++++++++